• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌中Keap1点突变引发其活性缺陷的结构基础。

Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer.

作者信息

Padmanabhan Balasundaram, Tong Kit I, Ohta Tsutomu, Nakamura Yoshihiro, Scharlock Maria, Ohtsuji Makiko, Kang Moon-Il, Kobayashi Akira, Yokoyama Shigeyuki, Yamamoto Masayuki

机构信息

RIKEN Genomic Sciences Center, Tsurumi, Yokohama 230-0045, Japan.

出版信息

Mol Cell. 2006 Mar 3;21(5):689-700. doi: 10.1016/j.molcel.2006.01.013.

DOI:10.1016/j.molcel.2006.01.013
PMID:16507366
Abstract

Nrf2 regulates the cellular oxidative stress response, whereas Keap1 represses Nrf2 through its molecular interaction. To elucidate the molecular mechanism of the Keap1 and Nrf2 interaction, we resolved the six-bladed beta propeller crystal structure of the Kelch/DGR and CTR domains of mouse Keap1 and revealed that extensive inter- and intrablade hydrogen bonds maintain the structural integrity and proper association of Keap1 with Nrf2. A peptide containing the ETGE motif of Nrf2 binds the beta propeller of Keap1 at the entrance of the central cavity on the bottom side via electrostatic interactions with conserved arginine residues. We found a somatic mutation and a gene variation in human lung cancer cells that change glycine to cysteine in the DGR domain, introducing local conformational changes that reduce Keap1's affinity for Nrf2. These results provide a structural basis for the loss of Keap1 function and gain of Nrf2 function.

摘要

Nrf2调节细胞氧化应激反应,而Keap1通过其分子相互作用抑制Nrf2。为阐明Keap1与Nrf2相互作用的分子机制,我们解析了小鼠Keap1的Kelch/DGR和CTR结构域的六叶β-螺旋桨晶体结构,发现广泛的叶片间和叶片内氢键维持了Keap1的结构完整性以及与Nrf2的正确结合。含有Nrf2的ETGE基序的肽通过与保守精氨酸残基的静电相互作用,在中央腔底部入口处与Keap1的β-螺旋桨结合。我们在人肺癌细胞中发现了一个体细胞突变和一个基因变异,它们在DGR结构域中将甘氨酸变为半胱氨酸,引入了局部构象变化,降低了Keap1对Nrf2的亲和力。这些结果为Keap1功能丧失和Nrf2功能获得提供了结构基础。

相似文献

1
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer.肺癌中Keap1点突变引发其活性缺陷的结构基础。
Mol Cell. 2006 Mar 3;21(5):689-700. doi: 10.1016/j.molcel.2006.01.013.
2
Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1.癌症相关体细胞突变对Keap1结构和靶标识别特性的分子影响。
Biochem J. 2015 Apr 1;467(1):141-51. doi: 10.1042/BJ20140761.
3
Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response.不同的静电势将ETGE和DLG基序定义为氧化应激反应中的铰链和锁扣。
Mol Cell Biol. 2007 Nov;27(21):7511-21. doi: 10.1128/MCB.00753-07. Epub 2007 Sep 4.
4
Crystal structure of the Kelch domain of human Keap1.人Keap1 Kelch结构域的晶体结构
J Biol Chem. 2004 Dec 24;279(52):54750-8. doi: 10.1074/jbc.M410073200. Epub 2004 Oct 8.
5
Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response.应激反应中Keap1的三种主要半胱氨酸传感器的特性
Mol Cell Biol. 2015 Nov 2;36(2):271-84. doi: 10.1128/MCB.00868-15. Print 2016 Jan 15.
6
Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model.Keap1通过与ETGE和DLG基序结合来招募Neh2:双位点分子识别模型的表征
Mol Cell Biol. 2006 Apr;26(8):2887-900. doi: 10.1128/MCB.26.8.2887-2900.2006.
7
Structural insights into the similar modes of Nrf2 transcription factor recognition by the cytoplasmic repressor Keap1.细胞质阻遏物Keap1识别Nrf2转录因子的相似模式的结构见解。
J Synchrotron Radiat. 2008 May;15(Pt 3):273-6. doi: 10.1107/S090904950705114X. Epub 2008 Apr 18.
8
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.Keap1与Nrf2的界面结构为Nrf2信号传导提供了机制上的见解。
EMBO J. 2006 Aug 9;25(15):3605-17. doi: 10.1038/sj.emboj.7601243. Epub 2006 Aug 3.
9
Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum.Nrf1转录因子的N端结构域对其进行的负调控不依赖于Keap1:Nrf1而非Nrf2定位于内质网。
Biochem J. 2006 Nov 1;399(3):373-85. doi: 10.1042/BJ20060725.
10
Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains.Keap1 是一个分叉茎二聚体结构,两个大球包含中间的双甘氨酸重复和 C 末端结构域。
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):2842-7. doi: 10.1073/pnas.0914036107. Epub 2010 Jan 27.

引用本文的文献

1
Living on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target.边缘生存:癌细胞中的活性氧稳态及其作为治疗靶点的潜力
Antioxidants (Basel). 2025 Aug 16;14(8):1002. doi: 10.3390/antiox14081002.
2
NRF2-dependent suppression of selenoprotein P expression promotes intracellular selenium metabolic remodeling and upregulation of antioxidant selenoproteins in hepatocellular carcinoma.NRF2依赖性抑制硒蛋白P表达促进肝细胞癌中的细胞内硒代谢重塑及抗氧化硒蛋白上调。
Redox Biol. 2025 Aug 13;86:103821. doi: 10.1016/j.redox.2025.103821.
3
Advances in KEAP1-based PROTACs as emerging therapeutic modalities: Structural basis and progress.
基于KEAP1的PROTACs作为新兴治疗方式的进展:结构基础与研究进展
Redox Biol. 2025 Jul 21;85:103781. doi: 10.1016/j.redox.2025.103781.
4
Nrf1 acts as a highly-conserved determinon for maintaining robust redox homeostasis in the eco-evo-devo process of life histories.Nrf1作为一个高度保守的决定因素,在生命历程的生态-进化-发育过程中维持强大的氧化还原稳态。
Cell Stress. 2025 Jul 7;9:65-142. doi: 10.15698/cst2025.07.306. eCollection 2025.
5
A novel β-TrCP1/NRF2 interaction inhibitor for effective anti-inflammatory therapy.一种用于有效抗炎治疗的新型β-TrCP1/NRF2相互作用抑制剂。
J Biomed Sci. 2025 Jul 11;32(1):65. doi: 10.1186/s12929-025-01157-3.
6
Involvement of KEAP1/NRF2 pathway in non-BRAF mutated squamous cell carcinoma of the thyroid.KEAP1/NRF2通路在非BRAF突变型甲状腺鳞状细胞癌中的作用
J Pathol. 2025 Aug;266(4-5):481-494. doi: 10.1002/path.6444. Epub 2025 Jul 2.
7
Unraveling the role of deuterium in cancer: mechanisms, detection techniques, and therapeutic potential.解析氘在癌症中的作用:作用机制、检测技术及治疗潜力
Mol Divers. 2025 Jun 7. doi: 10.1007/s11030-025-11221-7.
8
Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib's efficacy.富马酸二甲酯通过抑制Nrf2/Bcl-xL轴消除肝细胞癌生长并增强索拉非尼的疗效。
Sci Rep. 2025 May 14;15(1):16724. doi: 10.1038/s41598-025-00832-7.
9
Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment.UM171与新形态癌症突变体的结构模拟利用E3连接酶KBTBD4招募HDAC1/2。
Nat Commun. 2025 Apr 2;16(1):3144. doi: 10.1038/s41467-025-58350-z.
10
Thirty years of NRF2: advances and therapeutic challenges.NRF2的三十年:进展与治疗挑战
Nat Rev Drug Discov. 2025 Mar 4. doi: 10.1038/s41573-025-01145-0.